Blumenthal Stanley
Department of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Perspect Biol Med. 2009 Summer;52(3):343-54. doi: 10.1353/pbm.0.0091.
In 1960 Berson and Yalow published a method for the radioimmunoassay (RIA) of plasma insulin based on the concept that the extent to which unlabeled insulin displaces labeled insulin from anti-insulin antibody is proportional to the concentration of unlabeled insulin. The RIA for insulin has greatly increased knowledge of the physiology of glucose homeostasis and of the diverse causes of diabetes mellitus. Beyond this, the insight on which the RIA-or, more broadly, the competitive protein-binding assay-is based has provided the means to measure nanomolar or picomolar concentrations of a vast array of compounds in plasma and tissues. Directly or indirectly, the RIA has profoundly affected every branch of medicine. This essay reviews the ideas that were current in the medical research community when Berson and Yalow began their work and the observations and reasoning process that led them to their seminal discovery.
1960年,伯森和亚洛发表了一种基于未标记胰岛素从抗胰岛素抗体中取代标记胰岛素的程度与未标记胰岛素浓度成正比这一概念的血浆胰岛素放射免疫测定法(RIA)。胰岛素放射免疫测定法极大地增加了我们对葡萄糖稳态生理学以及糖尿病多种病因的了解。除此之外,放射免疫测定法(或者更广泛地说,竞争性蛋白结合测定法)所基于的见解为测量血浆和组织中大量化合物的纳摩尔或皮摩尔浓度提供了方法。放射免疫测定法直接或间接地深刻影响了医学的各个分支。本文回顾了伯森和亚洛开始他们的工作时医学研究界的流行观点,以及促使他们做出开创性发现的观察和推理过程。